Clinical Trials · NCT02012556
Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Theratechnologies
- Enrollment
- 18
- Start date
- May 2008
- Locations
- 1 site, Canada
- Primary endpoint
- Area under the Plasma Concentration versus Time Curve (AUC) of Tesamorelin.